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Abstract. Two simple and selective spectrophotometric methods are described for the determination of 
isoxsuprine hydrochloride (ISX·HCl) as base form in bulk drug and in injections and tablets. The methods 
are based on the molecular charge-transfer complexation of ISX base (ISX) with either p-chloranilic acid 
(PCA) or 2,3-dichloro-5,6-dicyano-1,4-benzoquinone (DDQ). The intense colored radical anions formed 
on dissociation, are quantitated at 520 nm (PCA method) or 600 nm (DDQ method). The optimum assay 
conditions were optimized. Beer's law is obeyed in the concentration ranges 5.28 × 10–5 to 42.2 × 10–5 mol 
dm–3 in PCA method and 0.79 × 10–5 to 10.6 × 10–5 mol dm–3 in DDQ method, with respective molar ab-
sorptivity values of 1.32 × 103 and 6.55 × 103 dm3 mol–1 cm–1. The reaction stoichiometry in both methods 
was evaluated by either Job’s method or limiting logarithmic method and was found to be 1:1 (ISX: PCA, 
ISX: DDQ). Developed methods were validated according to ICH guidelines and found to be accurate and 
precise. 
Keywords: isoxsuprine hydrochloride, p-chloranilic acid, 2,3-dichloro-5,6-dicyano-1,4-benzoquinone, 
spectrophotometry, injection, tablets 
 
INTRODUCTION 
Isoxsuprine hydrochloride (ISX) is chemically known as 
4-hydroxy-α-[1-[(1-methyl-2-phenoxyethyl) amino] ethyl] 
benzenemethanol hydrochloride (Figure 1). The main 
pharmacodynamic effects of ISX are induced by three 
mechanisms of action:1 a) stimulation of β-adrenergic 
receptors, largely predominant in the myometrium, con-
nected with the inhibitory relaxation responses of the 
smooth muscle fibres; b) inhibition of α-adrenergic recep-
tors prevalent in some arteries, connected with excitatory 
and vasoconstrictive responses; and c) direct, papaverine-
like spasmolysis of smooth muscles and the myometrium. 
The US pharmacopoeia2 recommends UV spectrophoto-
metric measurement of aqueous solution of ISX at 300 
nm, while the British pharmacopoeia3 recommends  
potentiometric titration using 0.1 M NaOH as titrant. 
Different techniques are available for the determina-
tion of ISX in both pharmaceuticals and biological matric-
es, and include UV spectrophotometry,4,5 ion selective 
electrode-potentiometry,6 chemiluminescence spectrome-
try,7 high performance liquid chromatography (HPLC),8–10 
gas chromatography (GC)11, GC-MS,12 LC-MS,13 affinity 
chromatography,14 polarography,15 and fluorimetry.16 
The presence of multi functional groups in ISX, 
viz. phenol, secondary amine and hydroxyl have re-
sulted in a number of color formation reactions for its 
spectrophotometric determination utilizing different 
reagents. The comprehensive review on the spectropho-
tometric methods reported until 2010 for the determina-
tion of ISX HCl or ISX was reported.17 Non-selectivity, 
multi-step reactions and strict pH control are some of 
the major disadvantages of the existing visible spectro-
photometric methods. The spectrophotometry continues 
to be most preferred technique for the assay of different 
classes of drugs in pure form, pharmaceutical formula-
tions and body fluids, because of its simplicity, reasona-
ble selectivity, accuracy and precision and cost-
effectiveness. Hence, a modest attempt has been made 
to develop spectrophotometric methods which would 
overcome some of the problems faced in most existing 
methods.  
Acetonitrile is the choice of the solvent in many 
charge transfer reaction.18–22 Acetonitrile is produced as 
a coincidental byproduct in the manufacture of acrylno-
titrile, which is used in the production of plastics and 
resins. A recent downturn in plastic production has 
resulted in severe shortages and escalating costs for 
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acetonitrile.23 Hence, we exploited the similar chemical 
properties of 1,4-dioxane for charge transfer reaction 
with DDQ instead of acetonitrile. DDQ in 1,4-dioxane 
was found to be stable for 4 days. The concentration of 
DDQ used in charge transfer reaction18–22 is 4.4 × 10–3 
or 8.8 × 10–3 mol dm–3 in acetonitrile which is monetari-
ly quite costly, where as, we found that a 2.2 × 10–3 mol 
dm–3 DDQ in 1,4 dioxane was sufficient. Further, DDQ 
charge transfer complex in acetonitrile absorbs max-
imally between 458–588 nm as reported,18–22 but the 
same reaction in 1,4-dioxane exhibited a bathochromic 
shift towards 600 nm, leading to improve sensitivity and 
selectivity. 
 
EXPERIMENTAL 
A Systronics model 106 digital spectrophotometer pro-
vided with 1 cm matched quartz cells was used for ab-
sorbance measurements. All chemicals were of analyti-
cal reagent grade of make from Merck or Loba Chemie, 
Mumbai, India, and distilled water was used to prepare 
the solutions. 
A 4.8 × 10–3 mol dm–3 PCA and 2.2 × 10–3 mol 
dm–3 DDQ solutions were prepared separately in  
1,4-dioxane. Carbonate-bicarbonate buffer of pH = 9.48 ± 
0.01 was prepared by dissolving 1.325 g of Na2CO3 and 
1.050 g of NaHCO3 in water and made up to the mark 
with same solvent in a 25 cm3 standard flask. 20 mg of 
pure ISX·HCl (99.85 % purity, Juggat Pharma, India) 
was dissolved in 10 cm3 water in a 125 cm3 separating 
funnel, 5 cm3 of carbonate-bicarbonate buffer of  
pH = 9.48 ± 0.01 was added followed by 20 cm3 of 
ethylacetate. The content was shaken for 15 minutes. 
The lower aqueous layer was discarded and the upper 
organic layer was collected in a beaker containing an-
hydrous sodium sulphate. The water-free organic layer 
was transferred into a dried beaker and the solvent eva-
porated on a hot water bath. The residue was dissolved 
in acetone, transferred to a 100 cm3 calibrated flask and 
diluted to volume with the same solvent. The resulting 
solution was diluted to get ISX concentrations of 5.3 × 
10–4 mol dm–3 and 1.3 × 10–4 mol dm–3 for PCA method 
and DDQ method, respectively. 
Procedures 
PCA Method 
Different aliquots of a standard ISX solution (0.5–4.0 
cm3, 5.3 × 10–4 mol dm–3) were transferred into a series 
of 5 cm3 calibrated flasks using micro burette and the 
total volume was adjusted to 4.0 cm3 with acetone. To 
each flask was added 1 cm3 of 4.8 × 10–3 mol dm–3 PCA 
solution. The absorbance of the resulting redish-pink 
chromogen was measured against the reagent blank at 
520 nm. 
 
DDQ Method 
Into a series of 5 cm3 calibrated flasks, 0.3–4.0 cm3 of 
1.3 × 10–4 mol dm–3 of standard ISX solution were add-
ed using micro burette and the total volume was made 
up to 4.0 cm3 with acetone. To each flask was added  
1 cm3 of 2.2 × 10–3 mol dm–3 DDQ solution. The absor-
bance of the resulting redish-violet product was meas-
ured against the reagent blank at 600 nm.  
In either case, the calibration graph was obtained 
for the absorbance vs. concentration of ISX and the 
concentration of the unknown was read from the cali-
bration or computed from the regression equation. 
 
Formulations 
Twenty tablets (Tidilan, Juggat Pharma, Bangalore-
560074, India) were weighed accurately and ground into 
a fine powder. A portion of the powder equivalent to 20 
mg of ISX was accurately weighed and transfer into 125 
cm3 separating funnel. The procedure extraction of ISX 
from the formulations was followed as done for pure 
ISX. The contents of ten injection tubes each containing 
2 cm3 of inject able product (5 mg ISX·HCl cm3) were 
pooled in a dry beaker. An aliquot equivalent to 20 mg 
of ISX·HCl was accurately measured into a separating 
funnel, and the steps described for tablets were fol-
lowed. 
 
Procedures for Method Validation  
Three different concentrations of ISX were analyzed in 
seven replicates during the same day (intra-day preci-
sion) and five consecutive days (inter-day precision) to 
study the method accuracy and precision. Selectivity 
was evaluated by both placebo blank analysis and re-
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covery studies. A placebo blank, the commonly em-
ployed tablet excipients, consisting of 20 mg sodium 
alginate, 30 mg magnesium stearate, 20 mg lactose, 20 
mg acacia, 50 mg talc and 30 mg starch, but without 
ISX was prepared as described in paragraph above. 
Following the similar extraction procedure, synthetic 
mixture was prepared by adding 10 mg of ISX·HCl to 
50 mg of placebo blank.  
 
RESULTS AND DISCUSSION 
PCA and DDQ are π acceptors. They form n-π type 
complex with n-electron donors. This is an intermediate 
molecular association complex which dissociates in to 
corresponding radical anions depending upon the polari-
ty of the solvent used.  
The basis of the proposed methods is the transfer 
of n-electrons from secondary amine of ISX to π ac-
ceptor such as p-chloranilic acid (PCA method) or  
2,3-dichloro-5,6-dicyano-1,4-benzoquinone (DDQ me-
thod) resulting in the formation of CT complexes which 
dissociate to form intensely colored radical anion. The 
transfer of non-bonding electrons is restricted in hy-
drochloride salt of isoxsuprine, i.e. ISX. HCl, hence 
hydrochloride was neutralized with buffer of pH = 9.48 ± 
0.01 and ISX was extracted into ethyl acetate before 
assay. The effort to skip extraction step by neutralizing 
HCl using methanolic KOH and NaOH prior to charge 
complex formation failed, because the methanolic KOH 
or NaOH gave yellow color product with both PCA and 
DDQ. Therefore, sample pretreatment by extraction of 
ISX into immiscible organic solvent is an inevitable 
step. 
Instead of acetonitrile, solvents such as acetone, 
methanol and chloroform were unsuitable because DDQ 
itself was found to be unstable in these solvents. PCA 
exists in unionized form in 1,4-dioxane.24 Further, ow-
ing to low dielectric constant, 1,4-dioxane, does not 
compete or shield the charge-transfer process from 
donor to acceptor which is necessary for instant and 
stable color formation at room temperature (about 25 
°C).25 The solution of PCA in 1,4-dioxane stored in an 
amber-glass bottle was found to be stable for at least 6 
weeks.25 Due to the structural similarity between PCA 
and DDQ, similar properties of PCA in 1,4-dioxane was 
observed in DDQ in 1,4-dioxane.  
The reddish-pink chromogen of PCA radical anion 
exhibits absorption maximum at 520 nm (Figure 2b) 
with negligible blank absorption (Figure 2a). The charge 
transfer complex between DDQ and ISX shows two 
absorption maxima at 440 nm and 600 nm (Figure 2d), 
with negligible blank absorption at either wavelength 
(Figure 2c). Some authors18,21,22 have considered analyt-
ical wavelength between 458–467 nm. When the same 
chromogen was measured against reagent blank, it exhi-
bited absorption maximum at 600 nm (Figure 2e). 
Therefore, all absorbance measurements were made at 
600 nm in DDQ method.  
The study of the effect of different solvents was 
restricted since the solubility of ISX is limited to ace-
tone, ethanol, methanol, DMF and DMSO. Acetone was 
found to be an ideal solvent as it afforded maximum 
sensitivity in both the methods. Effect of varying vo-
lumes of 9.5 × 10–3 mol dm–3 PCA and 4.4 × 10–3 mol 
dm–3 DDQ was studied on a fixed concentration of ISX. 
It was found that 0.5 cm3 each of 9.5 × 10–3 mol dm–3 
PCA and 4.4 × 10–3 mol dm–3 DDQ was sufficient to 
yield maximum sensitivity. Therefore, 1.0 cm3 each of 
4.8 × 10–3 mol dm–3 PCA and 2.2 × 10–3 mol dm–3 DDQ 
were used in actual procedure. 
 
Reaction Stoichiometry 
Job's method of continous variations of equimolar solu-
tions was employed to establish the stoichiometry of the 
PCA method. The solutions of ISX and PCA equivalent 
to 1.66 × 10–3 mol dm–3 were prepared in acetone and 
1,4-dioxane, respectively. The solutions were mixed in 
various proportions; the volume was completed to the 
mark with both acetone and 1,4-dioxane keeping the 
volume ratio of the two solvents as 1:1 in each flask. 
The resulting graph (Figure 3) shows that the interaction 
occurs on an equimolar basis (1:1 reaction stoichiome-
try), owing to the presence of one basic nitrogen con-
taining group. The Job's continuous variations technique 
failed in DDQ method. Therefore, the stoichiometry of 
the reaction was studied adopting the limiting logarith-
mic method.26 Two straight lines were obtained upon 
using increasing concentrations of DDQ while keeping 
the concentration of ISX constant (Figure 4a) and upon 
using increasing concentrations of ISX while keeping 
the concentration of the DDQ constant (Figure 4b). The 
 
Figure 2. Absorption spectra of: (a) blank vs. acetone – PCA 
method; (b) sample vs. acetone (ISX = 1.85 × 10–4 mol dm–3) –
PCA method; (c) blank vs. acetone; DDQ method; (d) sample vs. 
acetone (ISX = 9.24 × 10–5 mol dm–3) – DDQ method; (e) sample 
vs. reagent blank (ISX = 9.24 × 10–5 mol dm–3) –  DDQ method. 
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slopes of the two lines are 1.20 and 1.17. This means 
that the reaction proceeds in a molar ratio of 1.20:1.17 
i.e. in a ratio of ≈ 1:1. Hence, based on 1:1 (ISX:PCA, 
ISX:DDQ) reaction stoichiometry, a probable reaction 
scheme has been proposed (Figure 1).  
 
METHOD VALIDATION 
Analytical Data 
The linear regression equations were obtained by the 
method of least squares and the Beer's law range, molar 
absorptivity, correlation coefficient, variance, confi-
dence limits for slope and intercept for both methods are 
summarized in Table 1.  
The detection limit (LOD) and quantification limit 
(LOQ) were calculated by using the following equa-
tions:27  
 3.3 10LOD , LOQS S
R R
 
 
where S is the standard deviation of seven replicate 
determinations under the same conditions as for the 
sample in the absence of the analyte and R is the slope 
of the calibration graph. 
 
Precision and Accuracy 
The results obtained for the evaluation of precision and 
accuracy of the method is compiled in Table 2. 
 
Selectivity 
Upon analysis of placebo blank solution as shown under 
“Formulations”, the resulting absorbance readings for 
 
Figure 3. Job's continous variation plot, PCA method. 
  
 
 (a) (b) 
 
Figure 4. (a) Limiting logarithmic plots for the molar reactivity of DDQ with ISX: logarithm of absorbance vs. log [DDQ] at which 
[ISX] is kept constant; (b). logarithm absorbance vs. log [ISX] at which [DDQ] is kept constant. 
Table 1. Regression and analytical parameters 
Parameter PCA method DDQ method
max / nm 520 600 
Beer's law limits /  
(10–5 mol dm–3) 5.28–42.2 0.79– 10.6 
Molar absorptivity /  
(103 dm3 mol–1 cm–1) 1.32 6.55 
Limit of detection / 
(10–6 mol dm–3) 4.20 0.38 
Limit of quantification / 
(10–5 mol dm–3) 1.27 0.11 
Regression equation;(a) 
intercept, a 
slope, b 
 
–0.0085 
0.0138 
 
–0.0086 
0.0687 
Correlation coefficient, R 0.9994 0.9993 
Standard deviation of intercept, Sa 0.0067 0.0095 
(b)
a /tS n  0.0066 0.0088 
Standard deviation of slope, Sb 6.0 × 10–5 2.9 × 10–4 
(c)
b /tS n  5.8 × 10–5 2.7 × 10–4 
(a) y = a + bx, where y is the absorbance and x is concentration 
in mol dm –3. 
(b) Confidence limit for intercept. 
(c) Confidence limit for slope. 
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both the methods were same as reagent blank, inferring 
no interference from the placebo. Non interference from 
placebo was further confirmed by carrying out recovery 
study from synthetic mixture prepared by adding 10 mg 
of ISX to 50 mg of the placebo blank. The percent reco-
veries of ISX were 100.93 ± 0.63 and 102.56 ± 0.26 for 
PCA method and DDQ method, respectively. Hence 
confirms the selectivity of methods in the presence of 
the commonly employed tablet excipients. 
 
Application to Analysis of Formulations  
The proposed methods were successfully applied to the 
determination of ISX in tablets and injections (Table 3). 
The results obtained were statistically compared with 
those of the official method2 by applying the Students t-
test for accuracy and F-test for precision. The official 
method consisted of extraction of ISX from the matrices 
into aqueous solution and absorbance measured at 300 
nm. As can be seen from the Table 3, the calculated t- 
and F-value at 95 % confidence level did not exceed the 
tabulated values of 2.78 and 6.39, respectively, for four 
degrees of freedom. The results indicated that there is 
no difference between the proposed methods and the 
official method with respect to accuracy and precision. 
Accuracy of the proposed methods was further con-
firmed by standard-addition procedure. Pre-analyzed 
tablet powder (Tidilan 40 mg) and injection (Tidilan  
5 mg cm–3) was spiked with pure ISX at three different 
concentration levels (50, 100, and 150 % of the quantity 
present in the formulation) and the total was found by 
the proposed methods. The result of the recovery study 
is shown in Table 4. 
 
CONCLUSION 
Formation of n-π complex between n-electron donor 
ISX and π-acceptor PCA or DDQ is highly selective. 
Beside simple steps in sample pretreatment, the methods 
are accurate, precise, reproducible and applicable over 
wide linear dynamic ranges. Among the two methods, 
DDQ method is more sensitive with LOD = 0.38 × 10–6 
mol dm–3 whereas PCA method have LOD of 4.20 × 10–6 
mol dm–3. For the first time the charge transfer reaction 
with DDQ in 1,4-dioxane was used instead of common-
ly employed acetonitrile. Lower amount of DDQ for 
charge transfer complexation than normally used 4.4 × 
10–3 to 8.8 × 10–3 mol dm–3 in other solvents, and its 
high stability in 1,4-dioxane are two major advantages. 
Both the methods are rapid taking less than one minute 
for analysis, excluding ten minutes for sample prepara-
tion. The advantageous over the existing visible spec-
trophotometry is that the proposed methods are free 
from rigid experimental conditions like strict pH control 
or boiling steps.  
Table 2. Precision and accuracy 
Method ISX taken / (10–5 mol dm–3) 
Intra-day (n = 7) Inter-day (n = 5)
RSD / % RE / % RSD / % RE / %
PCA 
15.83 1.59 1.10 1.26 0.69 
26.40 0.89 1.85 1.11 1.51 
36.96 1.75 1.59 2.00 1.59 
DDQ 
3.96 2.05 2.78 1.33 4.04 
6.60 0.85 1.97 2.02 4.09 
9.24 1.60 1.08 1.76 0.65 
 
Table 3. Results of assay of formulations and statistical evalu-
ation 
Tablets/ 
injections 
Found(a) (percent of label claim ±SD) 
Reference method PCA method DDQ method 
Tidilan 
Tablet 
(100 mg) 
100.7 ±0.78 
99.85 ± 0.54 99.20 ± 1.56 
t = 2.03 t = 2.02 
F = 2.09 F = 4.00 
Tidilan 
Injection 
(5 mg) 
102.4 ± 0.63 
101.7 ± 1.61 103.1 ± 1.41 
t = 0.99 t = 1.08 
F = 6.53 F = 5.01 
(a) Mean value of 5 determinations ±SD; tabulated t- and F-value 
at 95 % confidence level are 2.78 and 6.39 respectively. 
Table 4. Results of recovery study by standard addition method 
Formulation studied 
PCA method DDQ method 
ISX in tablet / 
(10–5 mol dm–3) 
Pure ISX added / 
(10–5 mol dm–3)
Pure ISX 
recovered / %(a)
ISX intablet /
(10–5 mol dm–3)
Pure ISX added / 
(10–5 mol dm–3) 
Pure ISX 
recovered / %(a)
Tidilan Tablet 
9.55 5.280 104.7 ± 0.01 1.37 1.32 102.3±2.10 
9.55 10.56 99.91 ± 0.23 1.37 2.64 98.48 ± 0.22 
9.55 18.48 95.77 ± 1.20 1.37 3.96 95.20 ± 1.35 
Tidilan Injection 
13.92 10.56 102.4 ± 0.12 3.08 2.64 101.4 ± 0.58 
13.92 15.84 99.4 ± 0.21 3.08 3.96 103.1 ± 0.51 
13.92 21.12 101.5 ± 0.36 3.08 5.28 100.8 ± 0.22 
(a) Mean value ±SD; n = 3 
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SAŽETAK 
Spektrofotometrijsko određivanje baznog oblika izoksuprin  
hidroklorida pomoću kompleksa prijenosa naboja kod  
farmaceutskog oblikovanja 
Kanakapura Basavaiah, Kalsang Tharpa i Kanakapura Basavaiah Vinay 
Department of Chemistry, University of Mysore, Manasagangothri, Mysore-570006, India 
U ovom radu opisane su dvije jednostavne i selektivne metode za određivanje baznog oblika izoksuprin hidroklo-
rida (ISX·HCl) u sirovom lijeku u injekcijama i tabletama. Metode se baziraju na kompleksu prijenosa naboja 
između ISX baze (ISX) s p-kloranilnom kiselinom (PCA) ili 2,3-dikloro-5,6-dicijano-1,4-benzokinonom (DDQ). 
Intenzivno obojeni anioni radikala nastali disocijacijom, određeni su kavantitativno na 520 (PCA metoda) ili 600 
nm (DDQ metoda). Lambert Beerov zakon vrijedi za područje koncentracija od 5.28 × 10–5 do 42.2 × 10–5 mol 
dm–3 kod PCA metode, te od 0.79 × 10–5 do 10.6 × 10–5 mol dm–3 kod DDQ metode uz vrijednosti molarne ap-
sorptivnosti od 1.32 × 103 odnosno 6.55 × 103 dm3 mol–1 cm–1. Stehiometrija reakcije 1:1 (ISX: PCA, ISX: DDQ) 
kod obiju metoda određena je Jobovom ili graničnom logaritamskom metodom. Točnost i preciznost metoda oka-
rakterizirana je prema ICH mjerilima. 
